The Los Angeles Post
U.S. World Business Lifestyle
Today: March 20, 2025
Today: March 20, 2025

Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia

FILE PHOTO: Logo of German drugmaker Bayer AG in Leverkusen
June 26, 2024
Michael Erman - Reuters

By Michael Erman

NEW YORK (Reuters) - A top Bayer pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands as part of the company's internal reorganization.

The pharmaceutical unit has already cut around 40% of its managerial positions in the U.S. and has also implemented cuts in Canada, Mexico, Italy, Australia and the Nordic countries, Sebastian Guth, chief operating officer of Bayer Pharmaceuticals, said in an interview with Reuters.

Guth would not say exactly how many jobs the company has cut in those countries, but noted that "40% is sort of the range that we tend to see - some are a little lower and some are a little higher."

"We're not shooting for a specific number," Guth said. "For an organization of our size, there's just a lot of work that is being done that ultimately doesn't add value to customers and products."

According to Guth, the reorganization is already paying dividends. For example, the company was able to shave off around a year from its timeline for filing for regulatory approval for its higher dose formulation of its macular degeneration treatment Eylea in Europe.

Regeneron, which sells Eylea in the U.S., received approval for a high-dose version of the drug last year.

Bill Anderson, who became Bayer's CEO in June 2023, announced cuts to management late last year. He has had a tumultuous start, with a continued wave of litigation about an alleged cancer-causing effect of weedkiller glyphosate and a major setback in drug development late last year.

Anderson said in March that he would suspend for up to three years any preparations to break apart the German maker of pharmaceuticals, crop protection products and consumer health remedies.

(Reporting by Michael Erman; Editing by Paul Simao)

Related Articles

Trumpโ€™s AG pick Pam Bondi is more conventional than Gaetz, but the agenda to disrupt the Justice Department wonโ€™t change Nissan persuades US court to decertify brake defect class actions Boar's Head listeria outbreak is over with 10 dead and dozens sickened by tainted deli meat Daily Mirror publisher faces 101 phone-hacking lawsuits in UK
Share This

Popular

Business|Economy|Europe|Finance|Political

Bank of England set to keep main UK rate unchanged at 4.50% despite gloomy economic news

Bank of England set to keep main UK rate unchanged at 4.50% despite gloomy economic news
Asia|Business|Economy|Stock Markets|US

Stock market today: Asian shares are mostly higher after advance on Wall Street

Stock market today: Asian shares are mostly higher after advance on Wall Street
Asia|Business|Technology|World

Malaysia approves a new search for MH370 more than a decade after the plane disappeared

Malaysia approves a new search for MH370 more than a decade after the plane disappeared
Business|Economy|Finance|Political|Stock Markets|US

CNN's Matt Egan asks Fed Chair if he's worried about the stock market

CNN's Matt Egan asks Fed Chair if he's worried about the stock market

Health

Health|Political|US

Massive purge of Pentagon websites includes content on Holocaust remembrance, sexual assault and suicide prevention

Massive purge of Pentagon websites includes content on Holocaust remembrance, sexual assault and suicide prevention
Health|Political|US

US Senate Democrats demand reversal of CDC mass firings

US Senate Democrats demand reversal of CDC mass firings
Education|Health|Lifestyle

Man back home after losing 200 pounds

Man back home after losing 200 pounds
Crime|Health|US

Van veers off road into marsh; Officer rescues driver, 2 children

Van veers off road into marsh; Officer rescues driver, 2 children

Access this article for free.

Already have an account? Sign In